Market Research Assistance

On the Web
Refine Result

By Date

Last Month
Last 3 Months
Last 6 Months
Last Year
Last 2 Years

By Price

< $1000
$1000-$2500
$2501-$4000
$4001-$5500
$5501-$7500
$7501-$9000
>$9000

Arthritis therapeutics Market Research Reports

Titlepublishedprice

Ankylosing Spondylitis (Bekhterev's Disease)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

By Delve Insight
"...... urers across the globe. A key objective of the Ankylosing Spondylitis (Bekhterev's Disease) Report is to understand the market and pipeline status of the drugs around the Ankylosing Spondylitis (Bekhterev's Disease) to explore the generic development......"
01-Sep-2016$2000

Juvenile Arthritis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

By Delve Insight
"...... key objective of the Juvenile Arthritis Report is to understand the market and pipeline status of the drugs around the Juvenile Arthritis to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on d......"
01-Sep-2016$2000

Gouty Arthritis (Gout)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

By Delve Insight
"...... . A key objective of the Gouty Arthritis (Gout) Report is to understand the market and pipeline status of the drugs around the Gouty Arthritis (Gout) to explore the generic development opportunities, licensing opportunities and to gain competitive ad......"
01-Sep-2016$2000

Juvenile Rheumatoid Arthritis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

By Delve Insight
"...... e globe. A key objective of the Juvenile Rheumatoid Arthritis Report is to understand the market and pipeline status of the drugs around the Juvenile Rheumatoid Arthritis to explore the generic development opportunities, licensing opportunities and t......"
01-Sep-2016$2000

Osteoarthritis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

By Delve Insight
"...... objective of the Osteoarthritis Report is to understand the market and pipeline status of the drugs around the Osteoarthritis to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pip......"
01-Sep-2016$2000

Psoriatic Arthritis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

By Delve Insight
"...... key objective of the Psoriatic Arthritis Report is to understand the market and pipeline status of the drugs around the Psoriatic Arthritis to explore the generic development opportunities, licensing opportunities and to gain competitive advantage o......"
01-Sep-2016$2000

Rheumatoid Arthritis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

By Delve Insight
"...... A key objective of the Rheumatoid Arthritis Report is to understand the market and pipeline status of the drugs around the Rheumatoid Arthritis to explore the generic development opportunities, licensing opportunities and to gain competitive advantag......"
01-Sep-2016$2000

Systemic Juvenile Idiopathic Arthritis (SJIA)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

By Delve Insight
"...... turers across the globe. A key objective of the Systemic Juvenile Idiopathic Arthritis (SJIA) Report is to understand the market and pipeline status of the drugs around the Systemic Juvenile Idiopathic Arthritis (SJIA) to explore the generic developm......"
01-Sep-2016$2000

Systemic Juvenile Rheumatoid Arthritis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

By Delve Insight
"...... across the globe. A key objective of the Systemic Juvenile Rheumatoid Arthritis Report is to understand the market and pipeline status of the drugs around the Systemic Juvenile Rheumatoid Arthritis to explore the generic development opportunities, li......"
01-Sep-2016$2000

Arthritis Pain-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

By Delve Insight
"...... objective of the Arthritis Pain Report is to understand the market and pipeline status of the drugs around the Arthritis Pain to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pip......"
01-Sep-2016$2000